Can Hydrocodone Tablets Be Crushed?
Standard immediate-release hydrocodone/acetaminophen tablets can technically be crushed for patients with swallowing difficulties, but this practice should be avoided whenever possible due to safety risks for both the patient and the person handling the medication.
Key Considerations
Formulation Matters
The FDA labeling for hydrocodone bitartrate and acetaminophen tablets does not explicitly prohibit crushing standard immediate-release formulations 1. However, extended-release or abuse-deterrent formulations should never be crushed, as this destroys the controlled-release mechanism and can cause dangerous overdose 2, 3.
Risks of Crushing
For the patient:
- Altered absorption kinetics leading to rapid drug delivery and potential overdose 2
- Loss of dose uniformity, particularly when particles are milled below 500 μm 4
- Degradation of active ingredient when exposed to light, moisture, or food 2
- Increased risk of respiratory depression from bolus dosing 1
For the person crushing:
- Exposure to drug particles that can be absorbed through mucous membranes 5
- Occupational exposure to opioid compounds 2
Clinical Pitfalls
The most dangerous scenario involves intranasal abuse: crushing and snorting hydrocodone/acetaminophen causes severe nasal and oropharyngeal necrosis, septal perforations (51% of cases), palatal perforations (26%), and even fatal invasive fungal infections 5. This demonstrates the tissue toxicity of crushed formulations.
Practical Algorithm
If a patient cannot swallow tablets:
- First choice: Request liquid formulation from prescriber
- Second choice: Consider alternative opioid available in liquid form
- Last resort only: If crushing is absolutely necessary for immediate-release tablets:
- Crush immediately before administration (do not pre-crush)
- Mix with small amount of soft food (applesauce)
- Administer within minutes of crushing
- Use gloves and avoid creating dust
- Monitor closely for signs of overdose (respiratory depression, excessive sedation) 1
- Never crush extended-release formulations
Critical Warning
The CDC guidelines emphasize starting at the lowest effective dose (5-10 MME single dose, 20-30 MME/day) 6. Crushing tablets makes precise dosing more difficult and increases overdose risk, particularly when combined with the already narrow therapeutic window in elderly patients or those with renal/hepatic insufficiency 6.
Bottom line: While not absolutely contraindicated for immediate-release formulations, crushing hydrocodone tablets compromises patient safety and should only occur when no alternative exists, with appropriate precautions and monitoring in place.